Traphaco JSCSTC:TRA +4.49%82 Interest Coverage is 42.02 as of Mar. 2026, which is 40% below its 10-year median of 69.54. GuruFocus rates STC:TRA with a GF Score™ of 82/100 and a GF Value™ of ₫92,290.93 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 685 Drug Manufacturers companies, Traphaco JSC ranks better than 70.51% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Traphaco JSC's
Operating Income
for the
three
months ended in Mar. 2026 was ₫92,897 Mil. Traphaco JSC's Interest Expense for the
three
months ended in Mar. 2026 was ₫-2,211 Mil.
Traphaco JSC's interest coverage for the quarter that ended in Mar. 2026 was 42.02.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Traphaco JSC's Interest Coverage or its related term are showing as below:
STC:TRA'
s Interest Coverage Range Over the Past 10 Years
Min: 12.83 Med: 69.54 Max: 388.05
Current: 49.38
STC:TRA's Interest Coverage is ranked better than 70.51% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs STC:TRA: 49.38
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Traphaco JSC Interest Coverage Related Terms
Traphaco JSC Interest Coverage Historical Data
* Premium members only.
The historical data trend for Traphaco JSC's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Traphaco JSC's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Traphaco JSC Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Traphaco JSC's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Traphaco JSC's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Traphaco JSC (STC:TRA) has a Interest Coverage of 42.02 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Traphaco JSC and its competitors. This is 40% below median its historical median of 69.54. Over the past decade, Traphaco JSC's Interest Coverage has ranged from 12.83 to 388.05. According to the industry distribution chart, Traphaco JSC ranks #202 out of 685 companies in the Drug Manufacturers industry, placing it in the top 29.5%.
Is Traphaco JSC's Interest Coverage too high?
Traphaco JSC's current Interest Coverage of 42.02 is 40% below median its 10-year median of 69.54. Over the past 10 years, this metric has ranged from a low of 12.83 to a high of 388.05. The Drug Manufacturers industry median Interest Coverage is 12.78. Traphaco JSC's value of 42.02 is 228.8% above this industry median. Based on the distribution chart, Traphaco JSC ranks #202 out of 685 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Traphaco JSC has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Traphaco JSC's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Traphaco JSC ranks #202 out of 685 companies for Interest Coverage. This puts Traphaco JSC in the upper half of its industry. The industry median Interest Coverage is 12.78. Traphaco JSC's value of 42.02 is 228.8% above this benchmark. Historically, Traphaco JSC's own Interest Coverage has ranged from 12.83 to 388.05 over the past decade. While the company's 10-year median is 69.54 vs. the industry median of 12.78, Traphaco JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Traphaco JSC's current Interest Coverage of 42.02 is 228.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Traphaco JSC and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Traphaco JSC's current Interest Coverage is 42.02, which is 40% below median its own 10-year median of 69.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Traphaco JSC stock overvalued right now?
Based on GuruFocus' analysis, Traphaco JSC (STC:TRA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫92,290.93, compared to a current price of ₫81,400.00 — trading 11.8% below its estimated fair value. The current Interest Coverage is 42.02, which is 40% below median its 10-year median of 69.54 and 228.8% above the Drug Manufacturers industry median of 12.78. Traphaco JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Traphaco JSC (STC:TRA), the current Interest Coverage is 42.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Traphaco JSC (STC:TRA) Overvalued in 2026?
Based on GuruFocus' analysis, Traphaco JSC stock appears to be undervalued.
The current stock price of ₫81,400.00 is trading 11.8% below its estimated GF Value™ of ₫92,290.93.
GuruFocus considers Traphaco JSC to be Modestly Undervalued.
Key valuation signals for STC:TRA:
Interest Coverage: 42.02 (40% below median its 10-year median of 69.54)
GF Value™: ₫92,290.93 vs. price of ₫81,400.00 (11.8% below fair value)
Industry Position: 228.8% above the Drug Manufacturers median (#202 of 685)
No single metric tells the full story. See the STC:TRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Traphaco JSC is engaged in the production and trading of pharmaceuticals, chemicals, and medical supplies and equipment. The company's products are used for nourishing the body, the Skeletal system, for hair, for eyes, the Nervous system, the Respiratory system, and Other groups.
82GF Score
Get the complete analysis for STC:TRA
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:TRA has been successfully added to your 
